Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | UBE2N | P61088 | 1/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8845886 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL8179839 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL7561421 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL11116040 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL5353586 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL15153587 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL7614472 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL5353579 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL686346 | 0.98 | — | — | |
| SCHEMBL7699865 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-5326702-A | Hydrolysis of the nitrile | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-07-05 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-113574041-A | Method for producing bisphenol and method for producing polycarbonate resin | 三菱化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| WO-2020189201-A1 | METHOD FOR PRODUCING BISPHENOL AND METHOD FOR PRODUCING POLYCARBONATE RESIN | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| US-8822716-B2 | Intermediate of cilastatin and preparation method thereof | ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD (CN) | 2014-09-02 | — | — | US | disclosed |
| EP-1730177-B1 | CYANIDE TOLERANT NITRILHYDRATASES | EVONIK DEGUSSA GMBH (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-20110319653-A1 | Intermediate of Cilastatin and Preparation Method Thereof | ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD (CN) | 2011-12-29 | — | — | US | disclosed |
| US-7943359-B2 | Polynucleotides which code for cyanide-tolerant nitrile hydratase and compositions thereof | EVONIK DEGUSSA GMBH (DE) | 2011-05-17 | — | — | US | disclosed |
| US-20100261250-A1 | Cyanide-Tolerant Nitrile Hydratases | OSSWALD STEFFEN | 2010-10-14 | — | — | US | disclosed |
| EP-1308518-B2 | Method of producing carboxylic acids | DAICEL CHEM (JP) | 2010-09-22 | — | — | EP | disclosed |
| US-5288682-A | Catalyst for asymmetric induction | SUMITOMO CHEMICAL CO., LTD. (JP) | 1994-02-22 | — | — | US | disclosed |
| EP-0561637-A2 | A catalyst for asymmetric induction | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-09-22 | — | — | EP | disclosed |
| EP-0505089-A1 | A catalyst for asymmetric induction | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-09-23 | — | — | EP | disclosed |
| EP-0486289-A2 | Biological process for producing alpha-hydroxyamide or alpha-hydroxy acid | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-05-20 | — | — | EP | disclosed |
| US-4594099-A | Herbicide | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | disclosed |
| US-4511562-A | (Thio)(dithio-phosphates(phosphonates), processes for their preparation, and their use in pest-combating agents | BAYER AKTIENGESELLSCHAFT (DE) | 1985-04-16 | — | — | US | disclosed |
| US-4486600-A | Process for the production of β-hydroxy-α-aminocarboxylic acids | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-12-04 | — | — | US | disclosed |
| US-4482760-A | HYDROGENATING A CYANOHYDRIN | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-11-13 | — | — | US | disclosed |
| EP-0072482-A2 | (Thiono)(dithio)-phosphoric-(phosphonic)-acid esters, process for their preparation and their use as pesticides | BAYER AG (DE) | 1983-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261250-A1 | Cyanide-Tolerant Nitrile Hydratases | NANS, CPS1, ASNS | GPR84 3853/4885SPHK1 4373/4885FFAR1 2765/4885 |
| US-20110319653-A1 | Intermediate of Cilastatin and Preparation Method Thereof | CYP8B1, DHCR7, HMGCR | GPR84 3826/4885SPHK1 1201/4885FFAR1 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.